Author

Zehra Sadak Öcal

Institutions: Inonu University, Turgut Özal Tıp Merkezi

Observed institutions: Inonu University, Turgut Özal Tıp Merkezi

ORCID: 0009-0007-1822-1396

Observed ORCID: 0009-0007-1822-1396

OpenAlex ID: A5130646844

Diabetes Increases Immunotherapy‐Related Toxicity but Not Efficacy in Metastatic Non‐Small Cell Lung Cancer: A Multicenter Retrospective Study

2026 · Emre Çakır, Didem Divriklioğlu, et al. · International Journal of Cancer

Pretreatment Prognostic Nutritional Index Predicts Progression-Free Survival in BCLC Stage C Hepatocellular Carcinoma Treated with Sorafenib

2026 · Umut Aydın, Mustafa Dikilitaş, et al. · Cancer Management and Research

Adjuvant Chemotherapy Regimens in Resected Biliary Tract Cancers: National, Comparative, Observational Study ( TOG / GI ‐ SAFRADJU ‐2501)

2026 · Erman Akkus, Mehmet Kayaalp, et al. · International Journal of Cancer

Resectable Stage Early-Onset Biliary Tract Cancer: Survival and Prognostic Scoring (EOB-RS and EOB-OS) in Turkish Patients (TOG/GI-SAFRADJU-2502-EO)

2026 · Erman Akkus, Mehmet Kayaalp, et al. · JCO Global Oncology

Ürogenital Sistem Kanserleri

2025 · Leyla Beytur, Fırat Çağlar Budak, et al. · Akademisyen Kitabevi eBooks

Testis Tümörlerinde Tanı, Tarama, Etiyoloji ve Epidemiyoloji

2025 · Zehra Sadak Öcal · Akademisyen Kitabevi eBooks

İrritabl barsak sendromu tedavisinde trimebutin ve tegaserod'un etkinliklerinin karşılaştırılması / Efficacy of tegaserod and trimebutin in the treatment of patients with irritable bowel syndrome

2005 · Zehra Sadak Öcal · DSpace - FIRAT (Fırat University)

Works count: 7

Citation count:

H-index:

I10-index: